In the ER+HER2– BC group, the CPBS score was calculated by summing the prognostic categories for lymph node status, Ki67-entropy, mean of CD8+ cell density in the IZ tumor aspect, and ID of CD8+ cell density. The gene discussed is ERBB2; the disease is breast cancer.